The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's total assets are $89.36 Billion USD. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | $91.83 B | -5.47% |
2023-12-31 | $97.15 B | 49.19% |
2022-12-31 | $65.12 B | 6.47% |
2021-12-31 | $61.16 B | -2.83% |
2020-12-31 | $62.94 B | 5.43% |
2019-12-31 | $59.70 B | -10.1% |
2018-12-31 | $66.41 B | -16.93% |
2017-12-31 | $79.95 B | 3% |
2016-12-31 | $77.62 B | 8.65% |
2015-12-31 | $71.44 B | 3.54% |
2014-12-31 | $69.00 B | 4.36% |
2013-12-31 | $66.12 B | 21.78% |
2012-12-31 | $54.29 B | 11.1% |
2011-12-31 | $48.87 B | 12.38% |
2010-12-31 | $43.48 B | 9.73% |
2009-12-31 | $39.62 B | 8.74% |
2008-12-31 | $36.44 B | 5.21% |
2007-12-31 | $34.63 B | 2.52% |
2006-12-31 | $33.78 B | 15.33% |
2005-12-31 | $29.29 B | 0.26% |
2004-12-31 | $29.22 B | 11.9% |
2003-12-31 | $26.11 B | 6.78% |
2002-12-31 | $24.45 B | 279.57% |
2001-12-31 | $6.44 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $208.02 B | 132.78% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $92.42 B | 3.42% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $78.43 B | -12.23% | ๐ฌ๐ง UK |
![]() Gilead Sciences GILD | $56.43 B | -36.85% | ๐บ๐ธ USA |
![]() Biogen BIIB | $28.03 B | -68.63% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $136.16 B | 52.37% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $193.67 B | 116.71% | ๐บ๐ธ USA |
![]() Illumina ILMN | $6.18 B | -93.08% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $89.38 B | 0.02% | ๐บ๐ธ USA |